Peak Bio, Inc.

Peak Bio, Inc., trading under the ticker IGNY, is a special purpose acquisition company that conducted its initial public offering in 2021 with a stated focus on healthcare and biopharmaceutical targets. The company submitted a Form 10-Q to the U.S. Securities and Exchange Commission on July 26, 2021, under accession number 0001206774-21-001837, providing quarterly disclosure of its financial condition and business activity as a publicly traded blank-check vehicle. Oriented toward life-sciences deal-making, IGNY was among the healthcare-sector SPACs active during the busy 2021 market cycle. For sponsor details, full filing histories, and deal-stage analytics on IGNY and the broader SPAC universe, sign up for complete data access at SpacDesk.